Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LINC00667 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
HAVCR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
THBS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RWDD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLIPR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC16A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPBWR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLSTN2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIN28B-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
F5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD248 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNUPN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAUS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on